Anti-LAG-3 binding proteins
US10280221B2 · kind B2 · utility
1Cited by
10References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2014 |
| Grant date | May 7, 2019 |
| Priority date | — |
| Expiry date | Apr 21, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antigen binding proteins that bind Lymphocyte Activation Gene 3 (LAG-3), and more particularly to antigen binding proteins that cause depletion of LAG-3+ activated T cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.